禁煙治療薬の世界市場:ニコチン置換療法(NRT)、電子たばこ...市場調査レポートについてご紹介

【英文タイトル】Global Smoking Cessation Drugs Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: World cigarette statistics: Per capita consumption per year

PART 06: Epidemiology
• US

PART 07: Health implications of smoking
• Risk of tobacco smoke on non-smokers

PART 08: Regulations on tobacco use
• Impact of smoking bans on businesses
• Economic benefits to individuals

PART 09: Pipeline analysis
• NAL2762
• X-22
• APD356
• GSK598809
• SEL-068
• ARD-1600

PART 10: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 11: Market segmentation by type
• Global smoking cessation drugs market
• Global NRTs market
• Global e-cigarette market

PART 12: Market segmentation by availability
• Prescription products
• OTC products

PART 13: Geographical segmentation
• Global smoking cessation products market by geography 2015-2020
• Smoking cessation products market in Americas
• Smoking cessation products market in EMEA
• Smoking cessation products market in APAC

PART 14: Market drivers
• Increase in number of smokers
• Increase in teenage smoking
• Significant number of public awareness programs
• High awareness of risks associated with tobacco use

PART 15: Impact of drivers

PART 16: Market challenges
• Side effects associated with drugs and therapies
• Relapse after treatment
• Weak R&D on drugs

PART 17: Impact of drivers and challenges

PART 18: Market trends
• Increase in use of e-cigarettes
• Increased innovation in smoking cessation products
• Ban on tobacco advertisements
• Increased pictorial warnings on cigarette packages

PART 19: Vendor landscape
• Competitive scenario
• GlaxoSmithKline
• Imperial Tobacco
• NJOY
• Pfizer
• Reynolds American
• Other prominent vendors

PART 20: Appendix
• List of abbreviations

PART 21: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Common health effects caused by smoking
Exhibit 03: Smoking cessation products: Pipeline portfolio
Exhibit 04: Discontinued projects
Exhibit 05: Global smoking cessation products market 2015-2020 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Global smoking cessation products market by type
Exhibit 08: Global smoking cessation products market by type 2015
Exhibit 09: Global smoking cessation drugs market 2015-2020 ($ billions)
Exhibit 10: Global NRTs market 2015-2020 ($ billions)
Exhibit 11: Global NRTs market by product 2015
Exhibit 12: Global nicotine patch market 2015-2020 ($ billions)
Exhibit 13: Nicotine patch market by geographical region 2015
Exhibit 14: Global nicotine gum market 2015-2020 ($ billions)
Exhibit 15: Nicotine gum market by geographical region 2015
Exhibit 16: Global e-cigarette market 2015-2020 ($ billions)
Exhibit 17: Global e-cigarette market: Product life cycle analysis 2015
Exhibit 18: E-cigarette market by geographical region 2015
Exhibit 19: Global smoking cessation products market by availability
Exhibit 20: Global smoking cessation products market by geography 2015
Exhibit 21: Global smoking cessation products market by geography 2020
Exhibit 22: Global smoking cessation products market revenue by geography 2015-2020 ($ billions)
Exhibit 23: Smoking cessation products market in Americas 2015-2020 ($ billions)
Exhibit 24: Smoking cessation products market in EMEA 2015-2020 ($ billions)
Exhibit 25: Smoking cessation products market in APAC 2015-2020 ($ billions)
Exhibit 26: Impact of drivers
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Implementation of picture warnings in various countries
Exhibit 29: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 30: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 31: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 32: GlaxoSmithKline: Key takeaways
Exhibit 33: Imperial Tobacco: Business segmentation by revenue 2014
Exhibit 34: Imperial Tobacco: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 35: Imperial Tobacco: Key takeaways
Exhibit 36: NJOY: Product categories
Exhibit 37: NJOY: Key takeaways
Exhibit 38: Pfizer: Business segmentation by revenue 2014
Exhibit 39: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 40: Pfizer: Geographical segmentation by revenue 2014
Exhibit 41: Pfizer: YoY growth and revenue of Chantix or Champix ($ millions)
Exhibit 42: Pfizer: Key takeaways
Exhibit 43: Reynolds American: Business segmentation by revenue 2014
Exhibit 44: Reynolds American: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 45: Reynolds American: Key takeaways


【レポート販売概要】

■ タイトル:禁煙治療薬の世界市場:ニコチン置換療法(NRT)、電子たばこ
■ 英文:Global Smoking Cessation Drugs Market 2016-2020
■ 発行日:2016年4月27日
■ 調査会社:Technavio
■ 商品コード:IRTNTR8278
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。